AI-enabled technology platform delivers integrated pharmacovigilance solutions with measurable efficiency gains and enhanced compliance
The private funding rose 38% amid growing international collaborations and CDMO demand
The latest addition, a new API facility in Morrisville, North Carolina, will produce key components for solid dosage tablets, capsules, and RNA therapeutics
New pediatric nebulizer combines playful design and engaging features to make breathing treatments less stressful for children and parents
Approval marks the second generic semaglutide clearance in Canada and strengthens OneSource’s position in complex injectable CDMO programs
Under the new policy, financial assistance has been increased to Rs 50 lakh per patient to improve treatment access
Marking World Asthma Day 2026, doctors sounded the alarm over a steady surge in respiratory illnesses
The ISG assessment highlights Indegene’s deep domain expertise, proprietary technology stack, and expanding use of AI and GenAI to drive more integrated, data-led commercial execution across the life sciences value chain
The company secured new accounts, including ACCESS-PVI trial sites, and aims to strengthen global commercialization efforts
Subscribe To Our Newsletter & Stay Updated
